Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Wobser, M; Siedel, C; Schrama, D; Brocker, EB; Becker, JC; Vetter-Kauczok, CS.
Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Arch Dermatol Res. 2006; 297(8):352-357
Doi: 10.1007/s00403-005-0633-1
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Becker Jürgen Christian
- Co-Autor*innen der Med Uni Graz
- Schrama David
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Malignant melanoma of the skin preferentially metastasises via the lymphatic system. Novel molecular biomarkers, which are involved in malignant transformation, proliferation, angiogenesis and lymphangiogenesis, are currently under investigation to elucidate the risk for lymph node metastasis. To this end, the vascular endothelial growth factors VEGF-C and VEGF-D have been identified to promote lymphangiogenesis and lymphatic spread through activation of its receptor, Vascular endothelial growth factor receptor-3 (VEGFR-3). Prompted by this assumption, we estimated the degree of lymphangiogenesis by semiquantitative immunohistochemical analysis of the expression of VEGFR-3 and the panvascular marker CD31 in primary cutaneous melanoma (n=26) and correlated these findings with the sentinel lymph node (SLN) status. The cohort was selected for matched prognostic markers in SLN-positive and SLN-negative patients. In contrast to other studies, we observed an inverse correlation between expression of these markers with lymph node metastases. Additionally, no difference between intratumoral versus peritumoral CD31- or VEGFR-3 expression on blood vessels versus lymphatic capillaries could be detected. Interestingly, VEGFR-3 upregulation was not restrained to vascular structures but also appeared on tumor cells. In summary, in our series VEGFR-3/CD31 immunohistochemical staining of primary melanoma does not serve as a valid marker to predict lymph node involvement. As lymphatic spread is a complex, multi-step process, several different biomarkers have to be combined to define new prognostic subgroups in cutaneous melanoma.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Antigens, CD31 - analysis
- Cell Proliferation -
- Cell Transformation, Neoplastic -
- Female -
- Humans -
- Immunohistochemistry -
- Lymphangiogenesis -
- Lymphatic Metastasis - diagnosis
- Lymphatic Vessels - pathology
- Male -
- Melanoma - blood supply Melanoma - chemistry Melanoma - pathology Melanoma - secondary
- Middle Aged -
- Predictive Value of Tests -
- Prognosis -
- Risk Factors -
- Sentinel Lymph Node Biopsy -
- Skin Neoplasms - blood supply Skin Neoplasms - chemistry Skin Neoplasms - pathology
- Tumor Markers, Biological - analysis
- Vascular Endothelial Growth Factor Receptor-3 - analysis
- Find related publications in this database (Keywords)
- VEGFR-3
- CD31
- lymphangiogenesis
- sentinel lymph node biopsy
- malignant melanoma